Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jaypirca
Pharma
Bristol Myers bags FDA nod to bring CAR-T to CLL
BMS' Breyanzi, a one-time CAR-T therapy, will compete with Eli Lilly's Jaypirca, a chronic oral drug, in CLL following BTK and BCL-2 inhibitors.
Angus Liu
Mar 15, 2024 9:46am
Lilly’s Jaypirca tipped to capture 60% of BTK leukemia market
Jan 22, 2024 11:59am
Lilly's Jaypirca blazes CLL trail with FDA approval
Dec 4, 2023 4:11am
Lilly wins FDA approval for 4th BTK blood cancer drug
Jan 27, 2023 3:50pm
